Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Domperidone versus placebo for functional abdominal pain in children
IRCT20160308026973N2Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in functional abdominal pain (FAP) comparing Domperidone with Placebo (2 arms). Primary endpoint: Change at least 50% of the frequency of pain. Started Jan 2021; status: completed.
02
Drugs
domperidone
03
Conditions
functional abdominal pain (FAP)
Beyond the preview
Go deeper on IRCT20160308026973N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160308026973N2.